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The  lipopolysaccharide  (LPS)  1 component of the cell wall of gram-negative 
bacteria possesses a broad range of biological activities and has been utilized to 
probe both subcellular and cellular phenomena  (1-6).  It is known to stimulate 
cell-specific activity in a diversity of cell types, including platelets (7), polymor- 
phonuclear leukocytes (8),  lymphocytes (9),  fibroblasts (10),  and macrophages 
(11) among others.  Activation of lymphocytes has been studied in a  number of 
systems: LPS has been shown to be a  B-lymphocyte mitogen (12),  a  polyclonal 
B-lymphocyte  activator  (13),  and  an  in  vivo  adjuvant  (14)  enhancing  the 
antibody response to simultaneously administered  antigens.  Work by Claman 
(15) established that administration  of LPS after tolerogen interfered with the 
in vivo induction of tolerance.  Golub and Weigle (16) subsequently defined the 
temporal  relationship  between the injection of tolerogen  and  LPS.  Moreover, 
Louis, et al.  (17) showed that this regimen modulated the unresponsive state to 
one of immunity,  and  that  this  effect was limited  to  B  cells,  whose ensuing 
secondary response was T-independent in the face of continuing T-cell tolerance. 
Chiller  and  Weigle  (18)  demonstrated  that  LPS could be  used  to  terminate 
tolerance to human gamma globulin (HGG) late in tolerance, at a time when T 
cells were still tolerant but B cells were responsive. Under these circumstances, 
LPS was believed to be able to bypass the tolerant  T cells and activate HGG- 
specific B cells. 
In  1968,  Sultzer  (19) described a  mutant  C3H mouse,  the  C3H/HeJ,  which 
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appeared to be resistant to the effects of LPS. Further work with this strain has 
shown  that  it  is  refractory  to  virtually  all  LPS-mediated  effects  studied, 
including  endotoxic  shock  (20),  pattern  of  LPS-induced  polymorphonuclear 
leukocyte  changes  (21),  protection  from bacterial  infection  (22),  mitogenesis 
(23),  polyclonal B-cell activation  (24),  inhibition of tolerance induction  (25,  26), 
and in vivo adjuvanticity  (26). 
Recent work from this laboratory by Skidmore et al.  (27)  has demonstrated 
that the ability of C3H/HeJ spleen cells to be stimulated to mitogenesis by LPS 
is  dependent  upon  the  method  employed  in  extraction  of LPS.  Thus,  LPS 
extracted with the phenol-water technique of McIntire et al.  (28) was found to 
be  ineffective,  whereas  LPS  extracted  by  the  butanol-water  technique  of 
Morrison and Leive (29) or the trichloroacetic acid (TCA) technique of Boivin et 
al.  (30)  proved  to  be  a  potent  mitogen.  Nevertheless,  there  was  a  definite 
quantitative  difference between  the  responses  of C3H/HeJ  mice and  those  of 
LPS-responsive C3H/St mice to butanol-extracted  LPS.  The biochemical basis 
of these  observations  was  clarified  by  the  work  of Morrison  et  al.  (31)  and 
Sultzer and Goodman (32),  who showed that butanol-  and TCA-extracted LPS 
preparations contained a low molecular weight protein which was tightly bound 
to the lipid-A moiety of LPS, whereas the phenol-extracted preparation lacked 
this protein. Their observations demonstrated that in the C3H/HeJ mouse, this 
protein was the seat of the mitogenic activity of butanol and TCA extracts; the 
LPS from which the protein was separated was rendered nonmitogenic.  There- 
fore, the current studies were undertaken to learn whether or not the potency of 
butanol-extracted  LPS  in  C3H/HeJ  mice  extended  to  several  of  the  other 
immunological activities which LPS mediates in responder strains. 
Materials  and  Methods 
Mice.  C3H/St male mice, 6-12 wk of age, were obtained from the L. C. Strong Laboratory, Del 
Mar, Calif. C3H/HeJ male mice, 6-12 wk of age, were obtained from The Jackson Laboratory, Bar 
Harbor, Maine.  All  mice were  maintained on Wayne  Lab-Blox F6 pellets (Allied  Mills,  Inc., 
Chicago, Ill.) and chlorinated  water acidified with HCI to a pH of 3.0 (33). 
LPS.  Escherichia  coli  K235 was generously supplied  by Dr.  Arthur Hiram and Mr. Jerry 
Petruska of Abbott Diagnostics, North Chicago, Ill. LPS was extracted from these bacteria by the 
butanol-water technique (LPS-B) of Morrison and Leive (29). LPS extracted from E. coli K235 by 
a phenol-water technique (LPS-P) was kindly donated by Abbott Diagnostics, through Dr. Floyd 
McIntire at the University of Colorado School of Dentistry, Denver, Colo. 
Lymphocyte Cultures.  The preparation of spleen cell suspensions  and the constituents of the 
serum-containing culture media employed in these studies have been previously described (34). 
For measurement of pelyclonal  B-cell activation, lymphocytes were incubated in plastic culture 
trays (model 3008; Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) at a cell density of 1.0 × l0  T 
viable spleen cells/ml in a 1.0-ml volume. Culture trays were incubated at 37°C, in a humidified 
atmosphere containing a  mixture of 5% COs in air.  Cultures were fed daily with 20-40 gl of 
nutritional cocktail (35). The direct plaque forming cell (PFC) response to sheep erythrocytes and 
to trinitrophenyl (TNP) was assayed using a modification of the hemolytic plaque assay of Jerne 
and Nordin (36). 
HGG.  HGG was purified  from Cohn  Fraction  II,  as  previously described  (37), and  was 
obtained through the courtesy of the American Red Cross National Fractionation Center with the 
partial  support  of National  Institutes  of Health  grant  HE  13881 HEM.  The  methods  for 
preparation of HGG, aggregated by heating to 63°C for 25 min, or deaggregated by ultracentrifu- 
gation at 150,000 g for 150 min, have been detailed previously (38). The numbers of indirect PFC 
to HGG in individual  mice were assayed on goat erythrocytes conjugated to HGG with 1-ethyl-3- 
(3-dimethylaminopropyl)  carbodiimide  hydrochloride,  as detailed elsewhere (39). Assessment of 802  RESPONSIVENESS  TO  BUTANOL-EXTRACTED  LIPOPOLYSACCHARIDE 
indirect PFC was accomplished by use of a rabbit anti-mouse IgG amplifying serum. 
Cell Transfer.  Groups of primed and unprimed recipient mice were exposed  to 1,000 rads of 
whole body irradiation emitted from a Gamma Cell 40 small animal irradiator (Atomic Energy of 
Canada,  Ltd., Ottawa, Canada). This irradiator utilizes a cesium-137  source, emitting a central 
dose of 109 R/rain. Donor cells were prepared as single cell suspensions from the spleens of 90-day 
tolerant mice, washed twice in sterile balanced salt solution,  and viable cells enumerated by 
trypan blue dye exclusion. 35  ×  106 viable spleen cells were transferred to each recipient. 
Results 
Polyclonal  Activation  of C3H/HeJ  and  C3H/St  Spleen  Cell  Cultures  by 
Phenol- and Butanol-Extracted  LPS Preparations.  The abilities of a substance 
to function as a lymphocyte mitogen and as a polyclonal B-cell activator appear 
to  be  closely linked for most systems studied  (13,  40).  For this  reason,  the 
capacities of phenol-  and butanol-extracted K235  LPS  preparations  to  elicit 
polyclonal antibody responses were compared in C3H/HeJ and C3H/St mice. 1.0 
×  107  viable spleen cells/ml were cultured in a  1.0-ml volin the presence of 
incremental concentrations  of LPS-P  or  LPS-B.  48  h  later,  the  direct PFC 
responses to sheep erythrocytes (SRBC) and to TNP were assessed. The data 
presented  in  Figs.  1  and  2  indicate that  while  phenol-extracted LPS  is  an 
effective polyclonal B-cell activator for cultures of C3H/St  spleen cells,  it is 
ineffective in  the  C3H/HeJ  mouse  over  the  entire  range  of concentrations 
examined. Butanol-extracted LPS, on the other hand, is active in both strains. 
The polyclonal response increased directly with the concentration of LPS-B (and 
LPS-P in the C3H/St) for both antigens tested. In all cases, LPS-B was a more 
potent polyclonal B-cell activator than was LPS-P. 
Ability of Phenol- and Butanol-Extracted  LPS Preparations  to Enhance the 
Response  of C3H/HeJ and C3H/St Mice to HGG.  LPS, and in particular its 
lipid-A constituent, have been shown to possess the capacity to enhance the 
PFC response to protein antigens such as bovine serum albumin (14) or heat- 
aggregated human gamma globulin  (AHGG)  (41). Therefore, the capacity of 
LPS-B to function as an adjuvant for the PFC response to HGG was evaluated 
in  C3H/HeJ  and  C3H/St  mice.  Groups  of  six  mice  of  either  strain  were 
immunized with 400 ~g of AHGG i.v., followed 3 h  later by an i.v. injection of 
saline or a  variable amount of LPS-B.  An additional group received antigen 
followed by 100 ~g of LPS-P. The results of this type of experiment are seen in 
Fig.  3.  In the responder strain  (C3H/St),  the degree of enhancement of the 
indirect PFC response to HGG was directly related to the concentration of LPS- 
B  injected (the direct PFC  response to this  antigen is generally of very low 
magnitude, and reflected no LPS adjuvant effect in any case). In the C3H/HeJ, 
however, LPS-B failed to augment the response to HGG, regardless of the dose 
employed.  The  inability  of LPS-P  to  act  as  an  adjuvant  in  this  strain,  as 
observed by others (25), was confirmed in the present experiments (Fig. 3). In 
other experiments, when high doses of LPS-B were injected into C3H/HeJ mice 
after antigen administration, a  slight increase in PFC was observed, but was 
not found to be statistically significant. 
Inhibition  of Induction  of  Tolerance  to  HGG  by  LPS-B  in  C3H/HeJ 
Mice.  Previous work from this laboratory by Louis et al.  (17) has shown that 
injection of LPS into mice tolerized 3 h  previously with deaggregated human 
gamma globulin (DHGG) not only aborted the induction of tolerance, but also M.  G.  GOODMAN,  D.  E.  PARKS,  AND  W.  O.  WEIGLE 
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FIG.  l.  Polyclonal B-cell activation of C3H/St spleen cell cultures.  1.0  ×  10  ? viable C3H/ 
St  spleen cells were cultured  in  1  ml of 5% fetal calf serum-containing medium  in the 
presence of incremental concentrations of LPS-B or. LPS-P.  The direct PFC responses to 
SRBC and TNP were assayed 48 h  later.  Results are expressed as the arithmetic mean of 
triplicate cultures  -+ the standard error.  (am  B),  LPS-B anti-SRBC;  (O  .... O),  LPS-B 
anti-TNP; (In-- -in), LPS-P anti-SRBC; (@-- -O), LPS-P anti-TNP. 
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FIG.  2:  Polyclonal B-cell activation of C3H/HeJ spleen cell cultures. 1.0 x  10  ? viable C3H/ 
HeJ spleen cells were cultured in 1 ml of 5% fetal calf serum-containing medium in the 
presence of incremental concentrations of LPS-B or LPS-P.  The direct PFC responses to 
SRBC and TNP were assayed 48 h  later.  Results are expressed as the arithmetic mean of 
triplicate cultures  --- the standard error.  (B  I),  LPS-B anti-SRBC;  (O  O),  LPS-B 
anti-TNP; (I--  -m), LPS-P anti-SRBC; (O---O),  LPS-P anti-TNP. 
modulated the level of the response to one which is characteristic of antigen- 
primed animals. Therefore, experiments were undertaken to determine whether 
or  not  the responsiveness  of C3H/HeJ  mice to  LPS-B  would extend to  this 
parameter also. Groups of six C3H/HeJ mice were injected i.p. with either 2.5 mg 
of DHGG or saline.  3  h  afLer the tolerizing injection, mice received an i.v. 
injection of saline, or a variable amount of LPS-B. 30 days later, all mice were 
challenged with an immunogenic dose of aggregated HGG,  and the indirect 
PFC response to HGG was assayed 5 days after challenge. The results of this 
type of experiment are illustrated in Fig. 4. The dose-responsive nature of this 
phenomenon is illustrated for C3H/St mice in Fig. 4 A. The data presented in 
Fig. 4 B demonstrate that C3H/HeJ mice receiving tolerogen and no LPS were 
indeed tolerant, as were those receiving tolerogen followed by LPS-P. Although 804  RESPONSIVENESS  TO  BUTANOL-EXTRACTED  LIPOPOLYSACCHARIDE 
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FIG.  3.  Adjuvanticity of LPS-B and LPS-P for the in vivo anti-HGG PFC response. Groups 
of six C3H/St and C3H/HeJ mice were injected with 400 ~g AHGG i.v., followed 3 h later 
by injection of LPS-B, LPS-P, or an equal volume of saline, i.v. The indirect PFC response 
to HGG was assessed 7 days later. Results are expressed as the arithmetic mean of each 
group +- the standard error. [3, C3H/St; [], C3H/HeJ. 
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FIG.  4.  Ability of LPS-B and LPS-P to inhibit the induction of tolerance to HGG in C3H/ 
St and C3H/HeJ mice. Groups of six C3H/St and C3H/HeJ mice were injected with 2.5 mg 
DHGG or an equal volume of saline i.p., followed 3 h later by injection of LPS-B, LPS-P, or 
an equal volume of saline, i.v. All mice were challenged with an injection of 400 ~g AHGG 
i.v. after 30 days, and 5 days later the indirect PFC response to HGG was assessed. Results 
are expressed as the arithmetic mean of each group __- the standard error. The responses to 
LPS-P were evaluated in a separate experiment and normalized for control values. 
the groups treated with 1 and 10 ftg of LPS-B remained unresponsive to HGG 
cha]lenge, tolerance induction was aborted in all mice receiving 100 ~g of LPS- 
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FIG.  5.  Ability of LPS-B to bypass tolerant T cells late in HGG tolerance, in C3H/St and 
C3H/HeJ mice. Groups of six C3H/St and C3H/HeJ mice were injected with 2.5 mg DHGG 
or an equal volume of saline,  i.p.  All mice were challenged with an injection of 400  /~g 
AHGG i.v.  90 days later,  followed 3 h  later by injection of LPS-B or an equal volume of 
saline,  i.v.  The  indirect PFC  response  to  HGG was  assessed  6  days  later.  Results  are 
expressed as the arithmetic mean of each group -+ the standard error. [3, C3H/St; O, C3H/ 
HeJ. 
when treated with 25 fig of LPS-B,  and that 50 fig was effective in all cases. 
Thus, LPS-B is able to activate C3H/HeJ B cells to mitogenesis, to polyclonal 
antibody production, and to a  state of immunity under otherwise tolerogenic 
conditions, but it is unable to enhance the PFC response to protein antigens. 
Inability of  LPS-B Preparations to Bypass Tolerant T Cells Late in Tolerance 
to  HGG.  The kinetics of the maintenance of tolerance to  HGG have been 
studied in depth (42) and it has been shown that in A/J mice, tolerance persists 
for more than 4 mo at the level of the intact animal and of the thymus cell, 
whereas bone marrow-cell tolerance largely abates spontaneously about 50 days 
after tolerization. Moreover, if a  responder strain animal is challenged with 
antigen plus  LPS at a  time when its  B  cells are responsive and its  T  cells 
tolerant,  the  overall tolerance of the  animal  is  terminated, presumably by 
bypassing tolerant T cells using LPS as an alternate second signal (18). 
The ability of LPS-B to function in this manner was investigated in C3H/HeJ 
and C3H/St mice. Mice were injected i.p. either with saline or a tolerizing dose 
(2.5 mg) of DHGG. After 90 days, all animals were challenged with 400 ~g of 
the immunogen  AHGG i.v., followed 3 h later by the i.v. injection of  incremental 
concentrations of LPS-B.  The indirect PFC response of animals so treated was 
assayed 6 days later. The data presented in Fig. 5 illustrate that while LPS-B is 
able  to  activate  HGG-responsive  B  cells  in  the  C3H/St  strain  in  a  dose- 
dependent  fashion,  it  is  totally  ineffective in  the  C3H/HeJ  strain.  Other 
experiments demonstrated that LPS-P is equally inactive in this strain in this 
situation. Thus, there appears to be a clear distinction between the ability of 
LPS-B to inhibit tolerance induction and its inability to bypass tolerant T cells 
and so terminate tolerance in the C3H/HeJ mouse. 
To verify that 90 day-tolerant C3H/HeJ B cells are in fact responsive to HGG, 
cell transfer experiments were undertaken. Groups of 6 normal C3H/HeJ mice 
were injected with either 400/~g of AHGG to raise a population of HGC~specific 806  RESPONSIVENESS  TO  BUTANOL-EXTRACTED  LIPOPOLYSACCHARIDE 
TABLE  I 
Assessment of Tolerance of C3H/HeJ B Cells by Cell Transfer* 
Recipient 
Donor cells  iPFC/10  s 
Priming  Irradiation 
-  +  35  ×  106 90 DayTol  1 +_  0 
+  +  35  ×  l0  s 90 Day Tol  96  __-  7 
* Groups of 6 C3H/HeJ mice were injected with either 400 ~g AHGG or 
saline i.v. 7 days later, all mice were subjected to 1,000 rads of whole 
body irradiation, and injected with 35  ×  106 or no spleen cells from 
C3H/HeJ mice made tolerant 90 days previously with an i.p. injection 
of 2.5  mg  of DHGG.  All  mice  were  boosted with  AHGG  at  cell 
transfer and again 10 days later. Indirect PFC (iPFC) to HGG were 
determined 5 days later. All the mice in an additional group, which 
was primed and irradiated but which received no donor cells, died of 
radiation injury before plaquing. 
T helper cells, or with saline, i.v. 7 days later, all mice were subjected to 1,000 
rads of whole body irradiation, and injected with 35  ×  106  spleen cells from 
C3H/HeJ mice made tolerant 90 days previously. All mice were boosted with 
400 ~g AHGG at the time of cell transfer and again 10 days later. Indirect PFC 
to HGG were determined 5 days later. The data presented in Table I show that 
although the tolerance of the transferred cells remains intact, these previously 
tolerized cells do indeed respond to HGG challenge in the presence of radiore- 
sistant HGG-T helper cells. Thus, they must contain an HGG-responsive "B-cell 
population. 
Discussion 
The data presented herein establish the dichotomy in the ability of the C3H/ 
HeJ mouse to respond to LPS-B. LPS-B is able to stimulate C3H/HeJ B cells to 
mitogenesis and to polyclonal B-cell activation, but is unable to function as an 
adjuvant; it is able to inhibit tolerance induction, but cannot terminate the 
established tolerant state in this strain. The importance of these observations 
lies in their demonstration that these capacities are dissociable, very likely both 
genetically and in terms of the cell types required. 
Ever since Sultzer's original description (19) of the C3H/HeJ mouse as an 
endotoxin-resistant strain, much study has focused upon this strain. However, 
exceptions to its LPS-refractory state were noted, and in 1975, Skidmore et al. 
(27) observed that the C3H/HeJ could indeed respond mitogenically to LPS if it 
were extracted by the butanol-water technique of Morrison and Leive (29), or by 
the TCA technique of Boivin (30). Skidmore further demonstrated that LPS-B 
lost its stimulatory potential upon re-extraction with phenol. Recently, Morri- 
son,  et al.  (31) and Sultzer and Goodman (32) observed that re-extraction of 
TCA-  or  butanol-extracted LPS  in  phenol  cleaved a  low  molecular weight 
protein from the LPS molecule, and that this protein acted as a mitogen and a 
polyclonal B-cell  activator in the C3H/HeJ mouse. The residual protein-free 
LPS preparation was shown to be devoid of any such activity. 
The ability of LPS-B and the inability of LPS-P to activate C3H/HeJ spleen 
cells to polyclonal antibody production correlates with their respective mito- M.  G.  GOODMAN,  D.  E.  PARKS,  AND  W.  O.  WEIGLE  807 
genic capacities. In the responder strain (C3H/St),  both LPS preparations are 
effective polyclonal  activators.  This  is  precisely  the  pattern  of mitogenic 
reactivity demonstrated by Skidmore et al. (27) in these two strains, once again 
confirming the close biological linkage between mitogenicity and polyclonal B- 
cell activation. In marked contrast to the capacities of LPS-B to function as a 
mitogen and polyclonal B-cell  activator in  the  C3H/HeJ,  is  its  inability to 
function as an in vivo adjuvant of comparable potency to that demonstrated in 
C3H/St mice. This is true over the entire range of concentrations examined, in 
contradistinction to the marked effect produced in the C3H/St. Thus it appears 
that in the C3H/HeJ, LPS-B is able to fulfill some but not all of the biological 
roles that either LPS-B or LPS-P is able to assume in the C3H/St. 
A  functional  dichotomy is  also  observed  when  the  effects of LPS-B  on 
induction and termination of tolerance to HGG are studied in vivo in C3H/HeJ 
mice. In accord with the model established in A/J mice by Louis et al., LPS-B, 
administered to C3H/HeJ and C3H/St mice a~er an otherwise tolerogenic dose 
of DH~,  is able to inhibit the induction of tolerance. Upon challenge, these 
animals respond as if primed rather than tolerized. The observed difference in 
the  dose-response profiles  for inhibition  of tolerance induction for  the  two 
strains  would be  predicted on the  basis  of the  ability of C3H/St  mice and 
inability of C3H/HeJ mice to respond to the LPS moiety of LPS-B. Indeed, LPS- 
P was observed to inhibit tolerance induction in C3H/St but not in C3H/HeJ 
mice.  It  should  be  noted that  the  inability  of LPS-B  to  act  as  a  classical 
adjuvant, coupled with its ability to inhibit tolerance induction do not agree 
with Dresser's concept (43) that the latter phenomenon comprises a  stringent 
definition of adjuvanticity. The data presented hero would suggest that these 
two  situations  do  not  always  parallel  one  another,  and  that  inhibition  of 
tolerance induction should not be equated with adjuvanticity. The ability of 
LPS-B  to  abort  induction of tolerance in  C3H/HeJ  mice,  coupled with the 
ineffectiveness of LPS-P,  follows the same pattern observed for mitogenicity 
and polyclonal B-cell activation. 
In contrast to their effects on tolerance induction, neither LPS-B nor LPS-P is 
able to bypass tolerant T  cells late in tolerance to HGG in order to activate 
HGG-responsive C3H/HeJ B cells to antibody production. That the kinetic basis 
for this phenomenon as delineated in A/J mice (42) is also valid for C3H mice is 
supported by the ability of LPS-B to bypass tolerant T cells in late HGG-tolerant 
C3H/St mice. The lack of effectiveness  of LPS-B in C3I-I/HeJ mice in this situa- 
tion correlates with the inability of LPS-B to function as an adjuvant. C3H/HeJ 
B cells are fully responsive to HGG 90 days after tolerance induction. This was 
demonstrated by the ability of 90-day tolerant C3H/HeJ spleen cells to respond 
to HGG when transferred to lethally irradiated recipients which had previously 
been primed with HGG to generate a population of T helper cells. When T help 
was omitted, the recipients remained tolerant, underscoring the inability of 
LPS-B to transmit a T-cell-like signal to responsive C3H/HeJ B cells in the face 
of continued T-cell tolerance. 
Elucidation  of the  explanation  for  the  observed  pattern  of positive  and 
negative  LPS  responses  may be  approached  from  two  different directions: 
cellular  and  molecular.  One  might  first  consider  the  cellular  targets  and 
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have been shown to be unresponsive to the traditional form of LPS (LPS-P) in 
all  biological  situations  examined. A  comparison of the  protocols employed 
reveals that beth of the situations in which LPS-B  was ineffective involved 
injection of antigen 3 h before administration of LPS-B. Mitogenesis, polyclonal 
activation, and inhibition of tolerance induction, on the other hand, employed 
spleen cell populations which were predominantly resting.  It is conceivable, 
therefore, that once the initial steps of antigen-induced cellular activation have 
been traversed,  C3H/HeJ  B cells are not susceptible to the type of positive 
signal delivered by LPS-B.  This may represent a second defect in C3H/HeJ B 
cells.  Alternately,  adjuvanticity and  termination of tolerance  may require 
collaboration of HGG-specific B cells with a discrete subpopulation(s) of B cells 
which is either missing or unresponsive in the C3H/HeJ. 
A defect in the cellular response to LPS may not necessarily manifest itself at 
the  B-cell  level;  the  unresponsive state  may represent a  break  in cellular 
communication involving T cells, macrophages, or beth. The presence of T cells 
does not appear to be mandatory for the mitogenic response to LPS  (12, 44). 
Although there is some evidence to the contrary in the rabbit (45), T cells do not 
appear to be important in polyclonal activation (41, 46, 47). However, the PFC 
response to HGG is T-dependent, and there is some evidence to indicate that 
augmentation of the response to T-dependent antigens by LPS may involve T 
cells (46, 48). Ness et al.  (49) have shown that the adjuvant effect of LPS for 
synthetic polypeptide antigens has both T-independent and T-dependent facets. 
A C3H/HeJ T-cell defect, manifested expressly in the T-dependent aspects of 
LPS-induced adjuvanticity, might explain the absence of an  adjuvant effect 
seen with LPS-B in this strain. 
The role of T cells in inhibition of tolerance induction mediated by nonspecific 
B-cell activators appears to be minimal. This is demonstrated by the work of 
Schrader (50), who has  shown that polymerized flagellin  (POL)  can inhibit 
tolerance  induction  in  nu/nu  mice.  In  addition,  recent evidence from this 
laboratory by Parks et al.  (41), indicates that tolerance induction in C57BL/6J 
nu/nu mice can be inhibited by LPS. 
The role of T cells in LPS-mediated termination of tolerance is not clear. In 
this situation it is not likely that specific T help is the target cell for the action 
of LPS,  since kinetic studies  have  shown that  the  specific  T  cells are  still 
tolerant. Therefore, any T cell-LPS interaction would have to involve another 
group of T cells nonspecifically. If T cells constitute an essential component of 
the events involved in termination of tolerance, then either a defect in T-cell 
responsiveness to LPS or in B-cell responsiveness to the T cells involved could 
explain the unresponsiveness observed. 
Other evidence has pointed to a  defect in the responsiveness of C3H/HeJ 
macrophages  to  LPS  (22, 51). Several  investigators  have  shown  that  the 
presence  of macrophages  is  either  irrelevant  or  suppressive  to  mitogenic 
responses  (52, 53), and  is  not required for polyclonal B-cell  activation  (45). 
Macrophages constitute an integral part of the response to T-dependent anti- 
gens (54), and there is evidence to suggest a contributory role for macrophages 
in LPS-mediated adjuvanticity (55). However, macrophage dependency of the 
inhibitory effects of LPS on induction and maintenance of in vivo tolerance to 
heterologous serum proteins is unknown. Diener et al. (56) have shown that in M.  G.  GOODMAN,  D.  E.  PARKS,  AND  W.  O.  WEIGLE  809 
vitro  tolerance  to  the  T-independent antigen,  POL,  can  be  terminated  by 
normal macrophages. Therefore,  if macrophages were found to  constitute a 
critical component for in vivo adjuvanticity and termination of tolerance, but 
not for inhibition of tolerance induction, a defect in macrophage responsiveness 
to LPS or in B-cell responsiveness to the involved macrophages could explain 
the observed pattern of C3H/HeJ responses to LPS-B. 
The second direction from which the differential pattern of responsiveness 
may be  approached involves the molecular constitution of the probe.  Three 
possible molecular models could explain the activity of the LPS-B preparation 
in  C3H/HeJ  mice.  First,  all  activity  could  reside  in  the  lipid-A-associated 
protein (LAP) portion of the complex; the LPS component functioning simply as 
an inert carrier.  Second, binding of LAP could alter the configuration of the 
LPS molecule, exposing a site or sites that would be capable of activating the 
C3H/HeJ  B  cell.  Finally, some of the complex's effects could result from the 
action of LAP, whereas others would be attributable to LPS activated by LAP. 
If one were to postulate that the immunological effects of LPS-P are attribut- 
able to several distinct sites of action, one site would presumably be responsible 
for mitogenesis and pelyclonal B-cell activation; this site might or might not 
include that involved in inhibition of  tolerance induction. There is, in fact, some 
evidence that more than one site of action is involved in the biological activities 
of LPS: Jacobs and Morrison (57) have shown evidence for the dissociation of 
mitogenesis and T-independent immunogenicity, Poe and Michael  (58) have 
produced evidence for the functional dissociation of LPS-induced mitogenesis 
from  pelyclonal  activation,  and  Parks  et  al.  (41) have  found  a  pattern  of 
dissociation  of the  properties  of LPS  in  the  C57BL/6J  nude  mouse which 
parallels that described here.  This first site, responsible for mitogenesis and 
polyclonal activation, would be inhibitable by complexing LPS with pelymyxin 
B (59). A second site, then, would be the hypothetical seat of LPS adjuvanticity 
and its ability to bypass tolerant T cells. If the LAP moiety of LPS-B functions 
as an independent mitogen bound to an inert carrier, then LAP and possibly 
certain other B-cell mitogens would only be able to reproduce the immunological 
effects  due  to  the  first  site.  This  would  produce  the  pattern  of responses 
observed. Alternately,  LAP may activate the first site on the LPS molecule 
relative to the C3H/HeJ receptor but not the second. Finally, if there are three 
active sites on LPS,  LAP may be responsible for mitogenesis and pelyclonal 
activation in the C3H/HeJ, it may activate the site responsible for inhibition of 
tolerance induction, but be unable to activate the site involved in adjuvanticity 
and termination of tolerance. 
Summary 
The lipopolysaccharide (LPS)-protein complex extracted from the cell wall of 
Escherichia coli K235 by the butanol-water technique has been shown to evoke 
a  mitogenic response in bone marrow-derived (B)lymphocytes from the C3H/ 
HeJ mouse strain. These mice are resistant to the effects of LPS extracted with 
phenol. Therefore, the ability of butanol-extracted LPS to modulate a spectrum 
of C3H/HeJ B-cell functions was investigated. Both butanol-extracted (LPS-B) 
and phenol-extracted (LPS-P)  LPS preparations activated responder C3H/St 
spleen  cell  cultures  to  polyclonal  antibody  production,  while  only  LPS-B 810  RESPONSIVENESS  TO  BUTANOL-EXTRACTED  LIPOPOLYSACCHARIDE 
activated C3H/HeJ  spleen  cells.  Both  LPS-P and  LPS-B  acted  as  adjuvants 
when injected after aggregated human gamma globulin (HGG) in C3H/St mice, 
but neither preparation was effective as an adjuvant in C3H/HeJ mice. LPS-P 
injected with deaggregated HGG (tolerogen) into LPS-sensitive mice has been 
shown previously to inhibit the induction of tolerance to HGG. In the present 
studies, it was shown that LPS-B, but not LPS-P, was able to inhibit tolerance 
induction to HGG in the C3H/HeJ, whereas both preparations were effective in 
the C3H/St. LPS has also been shown to bypass tolerant T cells in LPS-sensitive 
mice late in tolerance to HGG at a time when B cells are responsive. However, 
in the C3H/HeJ, neither LPS-B nor LPS-P was capable of this function. The 
responsiveness of these B  cells to HGG was demonstrated in transfer experi- 
ments. Thus, in the C3H/HeJ, LPS-B stimulates mitogenesis, polyclonal B-cell 
activation, and inhibition of tolerance induction, but cannot act as an effective 
adjuvant or as a bypass mechanism to activate B cells in the presence of  tolerant 
T cells. The explanation for this pattern of responses may be attributable to yet 
another cellular defect in the C3H/HeJ mouse. 
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